THE GLOBAL MEDICAL EXOSKELETON MARKET SIZE WAS VALUED AT USD 595.40 MILLION IN 2021 AND IS EXPECTED TO REACH USD 3,816.17 MILLION BY 2027, GROWING AT A CAGR OF OVER 36% DURING 2022-2027

Medical Exoskeleton Market Size, Share, & Trends Analysis Report by

Modality: Powered Exoskeletons and Passive Exoskeletons
Extremity: Lower Extremity Exoskeletons and Upper Extremity Exoskeletons
Mobility: Mobile Exoskeletons and Stationary Exoskeletons),
Usage: Rehabilitation Exoskeletons and Augmentation Exoskeletons
Geography: North America, Europe, APAC, Latin America and the Middle East and Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

281 Pages

icon-table

109 Tables

icon-chart

126 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

29 Companies

icon-market

5 Market Segment

MEDICAL EXOSKELETON MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 3,816.17 MILLION (2027)
CAGR (REVENUE) OVER 36% (2022-2027)
BASE YEAR 2021
FORECAST PERIOD 2022 – 2027
MARKET SEGMENTS Modality (Powered Exoskeletons and Passive Exoskeletons), Extremity (Lower Extremity Exoskeletons and Upper Extremity Exoskeletons), Mobility (Mobile Exoskeletons and Stationary Exoskeletons), and Usage (Rehabilitation Exoskeletons and Augmentation Exoskeletons)
GEOGRAPHICAL ANALYSIS North America, Europe, APAC, Latin America and Middle East and Africa
COUNTRIES COVERED US, Canada, Germany, UK, France, Spain, Italy, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, South Africa.

MEDICAL EXOSKELETON MARKET OVERVIEW

The medical exoskeleton market was valued at USD 595.40 million in 2021 and is expected to reach USD 3,816.17 million by 2027, growing at a CAGR of 36.29% during the forecast period.

Government is responsible for ensuring that exoskeleton products sold in its region are accepted and meet market requirements. As a result, the government has enacted appropriate legislation to ensure that goals are achieved, product safety is the primary objective, and that the sale of unsafe products does not harm citizens. However, if commercialization involves technical product developments, a technical, regulatory framework in which the appropriate regional authorities enact legislation applicable to all levels of government (national, state, state, local, etc.) covering product services and actions. Governments and regulators' safety is a major concern before new products are generally commercially available. In this regard, only a few exoskeletons such as ReWalk, Ekso Bionics, and Cyberdyne have been certified to comply with the evolving international safety guidelines in medical and non-medical applications essential for the market growth.

SNIPPETS

  • Wearable robots and exoskeletons are used to assist in personal mobility. Exoskeletons deliver high-quality rehabilitation, thereby providing the base for a growth strategy for clinical facilities in the medical exoskeleton market.
  • 3D printing exoskeletons allow designing and producing parts with complex shapes and geometries without waste or composite materials. This technology gives the manufacturer design freedom and allows us to design customer-specific products in small quantities and at a low cost.
  • The most advanced version of the exoskeleton, HAL, Hybrid Assistive Limb, received FDA approval as an adjunct to medical procedures. FDA approval permits the use of HAL for rehabilitation of people with limb movement problems, thereby benefiting the market's growth.
  • The ALEX exoskeleton developed by SSSA is an example of a new exoskeleton device with unique properties in terms of kinematics and performance. The system can achieve a very low weight for the performance of 4 degrees of freedom, a series of elastic tendon transmission that guarantees an intrinsic mechanical elasticity.

MEDICAL EXOSKELETON MARKET SEGMENT ANALYSIS

  • Powered exoskeletons accounted for the larger share of the overall exoskeleton market in 2020. The high cost of powered exoskeletons leads to a higher market share of the technology than passive exoskeletons. Passive exoskeletons are often cheaper and lighter than powered exoskeleton, thereby, the combination of powered and passive exoskeleton characteristics in a new class of pseudo-passive (or semi-active) devices may provide a promising future direction for exoskeleton technology.
  • The ReWalk exoskeleton developed by ReWalk Robotics (Marlborough, MA, US) is a LEE that enables motorized movement of the hip and knee so that people with SCI can stand and walk upright. It is the first exoskeleton suit, approved by the US Food and Drug Administration in 2014, that can be used as a personal device at home and in the community, which propel the market's growth.
  • HAL (Hybrid Assistive Limb) was initially developed in ADL to help disabled people, but later versions were also developed for industrial applications. Over the past two decades, upper limb exoskeletons used for services and rehabilitation have received much attention from the biomedical and engineering sectors.
  • GT model Ekso exoskeleton Is the first exoskeleton approved in the United States. Food and Drug Administration (FDA). It is currently being evaluated by many centers in the United States and Europe. The EKSO exoskeleton, formerly known as the Lower Exoskeleton Motor System (eLEGS), was developed by Berkeley ExoWorks, a company known as EKSO Bionics.

VENDOR ANALYSIS

  • Massachusetts-based exoskeleton maker ReWalk Robotics. The company`s latest product, the augmentative ReWalk 6.0, uses cutting-edge technology to allow individuals with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, to stand, turn and walk.
  • Ekso Bionics, a Singapore-based company, announces a partnership with Australia's Royal Rehab to further expand the use of robotic exoskeletons in the Asia-Pacific region.
  • California's Ekso Bionics' Ekso GT is also a major rehabilitation exoskeleton, equipped with smart assist software, the physiotherapist can change the support for each leg device individually. This ability allows Ekso GT to rehabilitate more patients, from those too weak to walk to those who are almost independent, eventually for the market's growth.
  • Wearable Robotics' mission is to develop new solutions for robot training and rehabilitation. The company’s system is based on a new type of robot component, leading to ergonomic and easy-to-use treatment equipment. Wearable Robotics is a spin-off company from Scuola Superiore Sant` Anna, was born out of a long tradition of scientific research in the field of exoskeletons and wearable robots at Scuola Sant` Anna's PERCRO laboratory.
  • Gogoa, the first European company to obtain the CE mark for the HANK exoskeleton for lower limb rehabilitation. Gogoa develops solutions that are adapted to people for ease of use and user experience, to achieve them, clinical research and fitness tests will be conducted. Gogoa has an innovative personality by participating in the R + D + I project at home and abroad.

GEOGRAPHICAL ANALYSIS

  • The reason for the high uptake of the medical exoskeleton market in North America was contributed by the factors of the increasing elderly population, the prevalence of chronic illness, increasing strokes, rise in the number of the rehabilitation center, rise in prescriptions and hospitalization rates, increase in government funding and healthcare expenditure, as well as growing awareness of technological developments. The strong presence of key medical exoskeleton players is also another reason for the high uptake of the medical exoskeleton in North America.
  • APAC has a growing number of exoskeleton developers actively involved in the development of innovative medical exoskeletons at affordable cost. APAC is projected to grow at a lucrative rate due to an increase in stroke incidence, a growing aging population, related health conditions, favorable government policies, increasing healthcare expenditures are some of the factors driving the market.
  • Due to the driving factors in the market, as informed by WHO, Europe witnessed various developers of the medical exoskeleton, including leading players and many start-ups developing medical exoskeleton.
  • Ekso is the most widely used medical exoskeleton in the world and APAC, helping patients take more than 130 million steps worldwide. With Ekso Bionics' latest expansion plan in the Asia Pacific region, EksoNR already exists in Singapore, Malaysia, Taiwan, and Hong Kong.

KEY INDUSTRY PLAYERS

  • Ekso Bionics
  • ReWalk Robotics
  • PARKER HANNIFIN
  • Ottobock
  • CYBERDYNE
  • Rex Bionics
  • DIH Medical

Frequently Asked Questions

What is the size of the medical exoskeleton market and growth rate during the forecast period?

The global medical exoskeleton market was valued at USD 595.40 million in 2021 and is expected to reach USD 3,816.17 million by 2027, growing at a CAGR of 36.29%.

Which region is generating the largest revenue in the medical exoskeleton market?

North America holds the largest revenue in the medical exoskeleton market.

Who are the key players in the medical exoskeleton market?

Key players include Ekso Bionics, ReWalk Robotics, PARKER HANNIFIN, Ottobock, CYBERDYNE, Rex Bionics, DIH Medical.

What are the factors driving the market growth for the medical exoskeleton market?

The high demand for advanced medical technologies, increasing advanced exoskeleton manufacturers, the rising public and private healthcare expenditure, the rising elderly population, and the growing physical disabilities population are some of the factors that are fostering the market growth for the medical exoskeleton.

What are the opportunities in the medical exoskeleton market?

Existing global players account for dominant shares and have superior expertise in product development and marketing. New entrants should offer devices with lightweight and at a low cost to attain sustainability in the market.

Download Free Sample

The medical exoskeleton market by revenue is expected to grow at a CAGR of over 36% during the period 2022–2027.

The following factors are likely to contribute to the growth of the medical exoskeleton market.

  • The Emergence of Soft Actuator Medical Exoskeletons
  • Focus on Development of 3D- Printed Medical Exoskeletons
  • Increasing Focus on Developing Brain-Machine Interface Based Medical Exoskeleton
  • Increasing Number of People with Physical Disabilities
  • Recent Advancements in the Medical Exoskeleton
  • Increasing Insurance Coverage for Medical Exoskeleton

Base Year: 2021

Forecast year: 2022-2027

The report considers the present scenario of the medical exoskeleton market and its market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

PROMINENT VENDORS

  • Ekso bionics
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • ReWalk Robotics
  • PARKER HANNIFIN
  • Ottobock
  • CYBERDYNE
  • Rex Bionics
  • DIH Medical

OTHER PROMINENT VENDORS

  • Wearable Robotics
    • Business Overview
    • Product Offerings
  • Gogoa
  • ExoAtlet
  • Panasonic
  • Tyromotion
  • Honda Motor
  • B-Temia
  • Bionic Power
  • ANGEL ROBOTICS
  • AXOSUITS
  • BAMA Teknoloji
  • Biomotum
  • Bionic Yantra
  • Bioservo Technologies
  • Fourier Intelligence
  • FREE Bionics
  • Gloreha Idrogenet
  • Harmonic Bionics
  • HEXAR Humancare
  • Human in Motion Robotics
  • InteSpring
  • MARSI BIONICS

Market Segmentation by Modality

  • Powered Exoskeletons
  • Passive Exoskeletons

Market Segmentation by Extremity

  • Lower Extremity Exoskeletons
  • Upper Extremity Exoskeletons

Market Segmentation by Mobility

  • Mobile Exoskeletons
  • Stationary Exoskeletons

Market Segmentation by Usage

  • Rehabilitation Exoskeletons
  • Augmentation Exoskeletons

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • South Africa

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.1.3 Market Estimation Caveats

4.2 Base Year

4.3 Scope of The Study

4.4 Market Segmentation

4.4.1 Market Segmentation by Modality

4.4.2 Market Segmentation by Extremity

4.4.3 Market Segmentation by Mobility

4.4.4 Market Segmentation by Type

4.4.5 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Overview

8 Market Opportunities & Trends

8.1 Emergence of Soft Actuator Medical Exoskeletons

8.2 Development Of 3d-Printed Medical Exoskeletons

8.3 Increasing Focus on Brain-Machine Interface Based Medical Exoskeletons

9 Market Growth Enablers

9.1 Increasing Number of People with Physical Disabilities

9.2 Recent Advancements in Medical Exoskeletons

9.3 Increasing Insurance Coverage for Medical Exoskeletons

10 Market Restraints

10.1 High Cost of Medical Exoskeletons

10.2 Greater Preference for Wheelchairs

11 Market Landscape

11.1 Market Overview

11.2 Market Size & Forecast

11.3 Five Forces Analysis

11.3.1 Threat of New Entrants

11.3.2 Bargaining Power of Suppliers

11.3.3 Bargaining Power of Buyers

11.3.4 Threat of Substitutes

11.3.5 Competitive Rivalry

12 Modality

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Powered Exoskeleton

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.3.3 Powered Exoskeleton: Geography Segmentation

12.4 Passive Exoskeleton

12.4.1 Market Overview

12.4.2 Market Size & Forecast

12.4.3 Passive Exoskeleton: Geography Segmentation

13 Extremity

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Lower Extremity Exoskeletons

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.3.3 Lower Extremity Exoskeleton: Geography Segmentation

13.4 Upper Extremity Exoskeletons

13.4.1 Market Overview

13.4.2 Market Size & Forecast

13.4.3 Upper Extremity Exoskeleton: Geography Segmentation

14 Mobility

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Mobile Exoskeletons

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.3.3 Mobile Exoskeleton: Geography Segmentation

14.4 Stationary Exoskeletons

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.4.3 Stationary Exoskeleton: Geography Segmentation

15 Type

15.1 Market Snapshot & Growth Engine

15.2 Market Overview

15.3 Rehabilitation Exoskeletons

15.3.1 Market Overview

15.3.2 Market Size & Forecast

15.3.3 Rehabilitation Exoskeleton: Geography Segmentation

15.4 Augmentation Exoskeletons

15.4.1 Market Overview

15.4.2 Market Size & Forecast

15.4.3 Augmentation Exoskeleton: Geography Segmentation

16 Geography

16.1 Market Snapshot & Growth Engine

16.2 Geographic Overview

17 North America

17.1 Market Overview

17.2 Market Size & Forecast

17.2.1 North America: Modality Segmentation

17.2.2 North America: Extremity Segmentation

17.2.3 North America: Mobility Segmentation

17.2.4 North America: Type Segmentation

17.3 Key Countries

17.3.1 US: Market Size & Forecast

17.3.2 Canada: Market Size & Forecast

18 Europe

18.1 Market Overview

18.2 Market Size & Forecast

18.2.1 Europe: Modality Segmentation

18.2.2 Europe: Extremity Segmentation

18.2.3 Europe: Mobility Segmentation

18.2.4 Europe: Type Segmentation

18.3 Key Countries

18.3.1 Germany: Market Size & Forecast

18.3.2 UK: Market Size & Forecast

18.3.3 France: Market Size & Forecast

18.3.4 Spain: Market Size & Forecast

18.3.5 Italy: Market Size & Forecast

19 APAC

19.1 Market Overview

19.2 Market Size & Forecast

19.2.1 APAC: Modality Segmentation

19.2.2 APAC: Extremity Segmentation

19.2.3 APAC: Mobility Segmentation

19.2.4 APAC: Type Segmentation

19.3 Key Countries

19.3.1 China: Market Size & Forecast

19.3.2 Japan: Market Size & Forecast

19.3.3 India: Market Size & Forecast

19.3.4 Australia: Market Size & Forecast

19.3.5 South Korea: Market Size & Forecast

20 Latin America

20.1 Market Overview

20.2 Market Size & Forecast

20.2.1 Latin America: Modality Segmentation

20.2.2 Latin America: Extremity Segmentation

20.2.3 Latin America: Mobility Segmentation

20.2.4 Latin America: Type Segmentation

20.3 Key Countries

20.3.1 Brazil: Market Size & Forecast

20.3.2 Mexico: Market Size & Forecast

20.3.3 Argentina: Market Size & Forecast

21 Middle East & Africa

21.1 Market Overview

21.2 Market Size & Forecast

21.2.1 Middle East & Africa: Modality Segmentation

21.2.2 Middle East & Africa: Extremity Segmentation

21.2.3 Middle East & Africa: Mobility Segmentation

21.2.4 Middle East & Africa: Type Segmentation

21.3 Key Countries

21.3.1 Turkey: Market Size & Forecast

21.3.2 Saudi Araba: Market Size & Forecast

21.3.3 South Africa: Market Size & Forecast

22 Competitive Landscape

22.1 Competition Overview

22.2 Market Share Analysis

23 Key Company Profiles

23.1 EKSO BIONICS

23.1.1 Business Overview

23.1.2 Ekso Bionics in The Medical Exoskeleton Market

23.1.3 Product Offerings

23.1.4 Key Strategies

23.1.5 Key Strengths

23.1.6 Key Opportunities

23.2 REWALK ROBOTICS

23.2.1 Business Overview

23.2.2 Rewalk Robotics in The Medical Exoskeleton Market

23.2.3 Product Offerings

23.2.4 Key Strategies

23.2.5 Key Strengths

23.2.6 Key Opportunities

23.3 PARKER-HANNIFIN

23.3.1 Business Overview

23.3.2 Parker Hannifin in The Medical Exoskeleton Market

23.3.3 Product Offerings

23.3.4 Key Strategies

23.3.5 Key Strengths

23.3.6 Key Opportunities

23.4 OTTOBOCK

23.4.1 Business Overview

23.4.2 Ottobock in The Medical Exoskeleton Market

23.4.3 Product Offerings

23.4.4 Key Strategies

23.4.5 Key Strengths

23.4.6 Key Opportunities

23.5 CYBERDYNE

23.5.1 Business Overview

23.5.2 Cyberdyne in The Medical Exoskeleton Market

23.5.3 Product Offerings

23.5.4 Key Strategies

23.5.5 Key Strengths

23.5.6 Key Opportunities

23.6 REX BIONICS

23.6.1 Business Overview

23.6.2 Rex Bionics in Medical Exoskeleton

23.6.3 Product Offerings

23.6.4 Key Strategies

23.6.5 Key Strengths

23.6.6 Key Opportunities

23.7 DIH MEDICAL

23.7.1 Business Overview

23.7.2 Dih Medical in The Medical Exoskeleton Market

23.7.3 Product Offerings

23.7.4 Key Strategies

23.7.5 Key Strengths

23.7.6 Key Opportunities

24 Other Prominent Vendors

24.1 WEARABLE ROBOTICS

24.1.1 Business Overview

24.1.2 Product Offerings

24.2 GOGOA

24.2.1 Business Overview

24.2.2 Product Offerings

24.3 EXOATLET

24.3.1 Business Overview

24.3.2 Product Offerings

24.4 PANASONIC

24.4.1 Business Overview

24.4.2 Product Offerings

24.5 TYROMOTION

24.5.1 Business Overview

24.5.2 Product Offerings

24.6 HONDA

24.6.1 Business Overview

24.6.2 Product Offerings

24.7 B-TEMIA

24.7.1 Business Overview

24.7.2 Product Offerings

24.8 BIONIC POWER

24.8.1 Business Overview

24.8.2 Product Offerings

24.9 ANGEL ROBOTICS

24.9.1 Business Overview

24.9.2 Product Offerings

24.10 AXOSUITS

24.10.1 Business Overview

24.10.2 Product Offerings

24.11 BAMA TEKNOLOJI

24.11.1 Business Overview

24.11.2 Product Offerings

24.12 BIOMOTUM

24.12.1 Business Overview

24.12.2 Product Offerings

24.13 BIONIC YANTRA

24.13.1 Business Overview

24.13.2 Product Offerings

24.14 BIOSERVO TECHNOLOGIES

24.14.1 Business Overview

24.14.2 Product Offerings

24.15 FOURIER INTELLIGENCE

24.15.1 Business Overview

24.15.2 Product Offerings

24.16 FREE BIONICS

24.16.1 Business Overview

24.16.2 Product Offerings

24.17 GLOREHA IDROGENET

24.17.1 Business Overview

24.17.2 Product Offerings

24.18 HARMONIC BIONICS

24.18.1 Business Overview

24.18.2 Product Offerings

24.19 HEXAR HUMANCARE

24.19.1 Business Overview

24.19.2 Product Offerings

24.20 HUMAN IN MOTION ROBOTICS

24.20.1 Business Overview

24.20.2 Product Offerings

24.21 INTESPRING

24.21.1 Business Overview

24.21.2 Product Offerings

24.22 MARSI BIONICS

24.22.1 Business Overview

24.22.2 Product Offerings

25 Report Summary

25.1 Key Takeaways

25.2 Strategic Recommendations

26 Quantitative Summary

26.1 Market by Modality

26.1.1 North America: Modality Segmentation

26.1.2 Europe: Modality Segmentation

26.1.3 APAC: Modality Segmentation

26.1.4 Latin America: Modality Segmentation

26.1.5 Middle East & Africa: Modality Segmentation

26.2 Market by Extremity

26.2.1 North America: Extremity Segmentation

26.2.2 Europe: Extremity Segmentation

26.2.3 APAC: Extremity Segmentation

26.2.4 Latin America: Extremity Segmentation

26.2.5 Middle East & Africa: Extremity Segmentation

26.3 Market by Mobility

26.3.1 North America: Mobility Segmentation

26.3.2 Europe: Mobility Segmentation

26.3.3 APAC: Mobility Segmentation

26.3.4 Latin America: Mobility Segmentation

26.3.5 Middle East & Africa: Mobility Segmentation

26.4 Market by Type

26.4.1 North America: Type Segmentation

26.4.2 Europe: Type Segmentation

26.4.3 APAC: Type Segmentation

26.4.4 Latin America: Type Segmentation

26.4.5 Middle East & Africa: Type Segmentation

26.5 Market by Geography

26.5.1 Powered Exoskeleton

26.5.2 Passive Exoskeleton

26.5.3 Upper Extremity Exoskeleton

26.5.4 Lower Extremity Exoskeleton

26.5.5 Stationary Exoskeleton

26.5.6 Mobile Exoskeleton

26.5.7 Rehabilitation Exoskeleton

26.5.8 Augmentation Exoskeleton

27 Appendix

27.1 Abbreviations

LIST OF EXHIBITS            

Exhibit 1              Segmentation of Global Medical Exoskeleton Market

Exhibit 2              Market Size Calculation Approach 2021

Exhibit 3              Classification of Exoskeletons Based on End-Users

Exhibit 4              A Typical Model of Technical Regulatory System

Exhibit 5              Impact of the Emergence of Soft Actuator Medical Exoskeletons

Exhibit 6              Impact of Development of 3D-Printed Medical Exoskeletons

Exhibit 7              Impact of Increasing Focus on Brain-Machine Interface Based Medical Exoskeletons

Exhibit 8              Impact of Increasing Number of People with Physical Disabilities

Exhibit 9              Impact of Recent Advancements in Medical Exoskeletons

Exhibit 10            Impact of Increasing Insurance Coverage for Medical Exoskeletons

Exhibit 11            Impact of High Cost of Medical Exoskeletons

Exhibit 12            Impact of Greater Preference for Wheelchairs

Exhibit 13            Global Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 14            Five Forces Analysis 2021

Exhibit 15            Incremental Growth by Modality 2021 & 2027

Exhibit 16            Global Medical Exoskeleton Market by Modality

Exhibit 17            Global Medical Exoskeleton Market by Modality: Incremental Growth

Exhibit 18            Global Medical Exoskeleton Market by Modality: Absolute Growth

Exhibit 19            Global Powered Medical Exoskeleton Market: Incremental & Absolute Growth Comparison

Exhibit 20            Global Powered Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 21            Incremental Growth by Geography 2021 & 2027

Exhibit 22            Global Passive Medical Exoskeleton Market: Incremental & Absolute Growth

Exhibit 23            Global Passive Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 24            Incremental Growth by Geography 2021 & 2027

Exhibit 25            Incremental Growth by Extremity 2021 & 2027

Exhibit 26            Global Medical Exoskeleton Market by Extremity

Exhibit 27            Global Medical Exoskeleton Market by Extremity: Incremental Growth

Exhibit 28            Global Medical Exoskeleton Market by Extremity: Absolute Growth

Exhibit 29            Global Lower Extremity Medical Exoskeleton Market: Incremental & Absolute Growth

Exhibit 30            Global Lower Extremity Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 31            Incremental Growth by Geography 2021 & 2027

Exhibit 32            Global Upper Extremity Medical Exoskeleton Market: Incremental & Absolute Growth

Exhibit 33            Global Upper Extremity Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 34            Incremental Growth by Geography 2021 & 2027

Exhibit 35            Incremental Growth by Mobility 2021 & 2027

Exhibit 36            Global Medical Exoskeleton Market by Mobility

Exhibit 37            Global Medical Exoskeleton Market by Mobility: Incremental Growth

Exhibit 38            Global Medical Exoskeleton Market by Mobility: Absolute Growth

Exhibit 39            Global Mobile Medical Exoskeleton Market: Incremental & Absolute Growth

Exhibit 40            Global Mobile Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 41            Incremental Growth by Geography 2021 & 2027

Exhibit 42            Global Stationary Medical Exoskeleton Market: Incremental & Absolute Growth

Exhibit 43            Global Stationary Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 44            Incremental Growth by Geography 2021 & 2027

Exhibit 45            Incremental Growth by Type 2021 & 2027

Exhibit 46            Global Medical Exoskeleton Market by Type

Exhibit 47            Global Medical Exoskeleton Market by Type: Incremental Growth

Exhibit 48            Global Medical Exoskeleton Market by Type: Absolute Growth

Exhibit 49            Global Rehabilitation Medical Exoskeleton Market: Incremental & Absolute Growth

Exhibit 50            Global Rehabilitation Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 51            Incremental Growth by Geography 2021 & 2027

Exhibit 52            Global Augmentation Medical Exoskeleton Market: Incremental & Absolute Growth

Exhibit 53            Global Augmentation Medical Exoskeleton Market 2021–2027 ($ million)

Exhibit 54            Incremental Growth by Geography 2021 & 2027

Exhibit 55            Incremental Growth by Geography 2021 & 2027

Exhibit 56            Global Medical Exoskeleton Market by Geography

Exhibit 57            Global Medical Exoskeleton Market by Geography: Key Countries ($ million)

Exhibit 58            Global Medical Exoskeleton Market by Geography: Incremental Growth

Exhibit 59            Global Medical Exoskeleton Market by Geography: Absolute Growth

Exhibit 60            Medical Exoskeleton Market in North America: Key Countries

Exhibit 61            Global Medical Exoskeleton Market in North America: Incremental & Absolute Growth

Exhibit 62            Medical Exoskeleton Market in North America 2021–2027 ($ million)

Exhibit 63            Incremental Growth by Modality 2021 & 2027

Exhibit 64            Incremental Growth by Extremity 2021 & 2027

Exhibit 65            Incremental Growth by Mobility 2021 & 2027

Exhibit 66            Incremental Growth by Type 2021 & 2027

Exhibit 67            Incremental Growth in North America 2021 & 2027

Exhibit 68            Medical Exoskeleton Market in the US 2021–2027 ($ million)

Exhibit 69            Medical Exoskeleton Market in Canada 2021–2027 ($ million)

Exhibit 70            Medical Exoskeleton Market in Europe: Key Countries

Exhibit 71            Medical Exoskeleton Market in Europe: Incremental & Absolute Growth

Exhibit 72            Medical Exoskeleton Market in Europe 2021–2027 ($ million)

Exhibit 73            Incremental Growth by Modality 2021 & 2027

Exhibit 74            Incremental Growth by Extremity 2021 & 2027

Exhibit 75            Incremental Growth by Mobility 2021 & 2027

Exhibit 76            Incremental Growth by Type 2021 & 2027

Exhibit 77            Incremental Growth in Europe 2021 & 2027

Exhibit 78            Medical Exoskeleton Market in Germany 2021–2027 ($ million)

Exhibit 79            Medical Exoskeleton Market in the UK 2021–2027 ($ million)

Exhibit 80            Medical Exoskeleton Market in France 2021–2027 ($ million)

Exhibit 81            Medical Exoskeleton Market in Spain 2021–2027 ($ million)

Exhibit 82            Medical Exoskeleton Market in Italy 2021–2027 ($ million)

Exhibit 83            Medical Exoskeleton Market in APAC: Key Countries

Exhibit 84            Medical Exoskeleton Market in APAC: Incremental & Absolute Growth

Exhibit 85            Medical Exoskeleton Market in APAC 2021–2027 ($ million)

Exhibit 86            Incremental Growth by Modality 2021 & 2027

Exhibit 87            Incremental Growth by Extremity 2021 & 2027

Exhibit 88            Incremental Growth by Mobility 2021 & 2027

Exhibit 89            Incremental Growth by Type 2021 & 2027

Exhibit 90            Incremental Growth in APAC 2021 & 2027

Exhibit 91            Medical Exoskeleton Market in China 2021–2027 ($ million)

Exhibit 92            Medical Exoskeleton Market in Japan 2021–2027 ($ million)

Exhibit 93            Medical Exoskeleton Market in India 2021–2027 ($ million)

Exhibit 94            Medical Exoskeleton Market in Australia 2021–2027 ($ million)

Exhibit 95            Medical Exoskeleton Market in South Korea 2021–2027 ($ million)

Exhibit 96            Medical Exoskeleton Market in Latin America: Key Countries

Exhibit 97            Medical Exoskeleton Market in Latin America: Incremental & Absolute Growth

Exhibit 98            Medical Exoskeleton Market in Latin America 2021–2027 ($ million)

Exhibit 99            Incremental Growth by Modality 2021 & 2027

Exhibit 100         Incremental Growth by Extremity 2021 & 2027

Exhibit 101         Incremental Growth by Mobility 2021 & 2027

Exhibit 102         Incremental Growth by Type 2021 & 2027

Exhibit 103         Incremental Growth in Latin America 2021 & 2027

Exhibit 104         Medical Exoskeleton Market in Brazil 2021–2027 ($ million)

Exhibit 105         Medical Exoskeleton Market in Mexico 2021–2027 ($ million)

Exhibit 106         Medical Exoskeleton Market in Argentina 2021–2027 ($ million)

Exhibit 107         Medical Exoskeleton Market in the Middle East & Africa: Key Countries

Exhibit 108         Medical Exoskeleton Market in Latin America: Incremental & Absolute Growth

Exhibit 109         Medical Exoskeleton Market in the Middle East & Africa 2021–2027 ($ million)

Exhibit 110         Incremental Growth by Modality 2021 & 2027

Exhibit 111         Incremental Growth by Extremity 2021 & 2027

Exhibit 112         Incremental Growth by Mobility 2021 & 2027

Exhibit 113         Incremental Growth by Type 2021 & 2027

Exhibit 114         Incremental Growth in the Middle East & Africa 2021 & 2027

Exhibit 115         Medical Exoskeleton Market in Turkey 2021–2027 ($ million)

Exhibit 116         Medical Exoskeleton Market in Saudi Arabia 2021–2027 ($ million)

Exhibit 117         Medical Exoskeleton Market in South Africa 2021–2027 ($ million)

Exhibit 118         Ekso Bionics: Total Revenues 2018–2020 ($ million)

Exhibit 119         Ekso Bionics: R&D Expenditure 2018–2020 ($ million)

Exhibit 120         Ekso Bionics: Revenue by Region 2018–2020 ($ million)

Exhibit 121         Ekso Bionics: Revenue by Segment 2018–2020 ($ million)

Exhibit 122         ReWalk Robotics: Total Revenues 2018–2020 ($ million)

Exhibit 123         ReWalk Robotics: R&D Expenditure 2018–2020 ($ million)

Exhibit 124         ReWalk Robotics: Revenue by Geography 2018–2020 (%)

Exhibit 125         Parker Hannifin: Total Revenues 2018–2020 ($ million)

Exhibit 126         Parker Hannifin: Revenue by Geography 2019–2021 ($ million)

                       

LIST OF TABLES

Table 1             Key Caveats

Table 2              Currency Conversion 2015−2021

Table 3              Examples of Soft Actuator Medical Exoskeletons

Table 4              Examples of 3D-Printed Medical Exoskeletons

Table 5               EEG-based Control for Lower & Upper Limb Movements Exoskeletons

Table 6               Global Medical Exoskeleton Market by Geography

Table 7               Global Medical Exoskeleton Market by Modality

Table 8               Global Medical Exoskeleton Market by Extremity

Table 9                Global Medical Exoskeleton Market by Mobility

Table 10              Global Medical Exoskeleton Market by Type

Table 11              Some Commercial Powered Exoskeleton Products

Table 12              Overview of the Available Lower Extremity Medical Exoskeleton

Table 13              Stationary Medical Exoskeletons

Table 14              Major Medical Exoskeleton Startups in Europe

Table 15              Ekso Bionics: Major Product Offerings

Table 16              ReWalk Robotics: Major Product Offerings

Table 17              Parker Hannifin: Major Product Offerings

Table 18              Ottobock: Major Product Offerings

Table 19              Cyberdyne: Major Product Offerings

Table 20              Rex Bionics: Major Product Offerings

Table 21              DIH Medical: Major Product Offerings

Table 22              Wearable Robotics: Major Product Offerings

Table 23              Gogoa: Major Product Offerings

Table 24              ExoAtlet: Major Product Offerings

Table 25              Panasonic: Major Product Offerings

Table 26              Tyromotion: Major Product Offerings

Table 27              Honda: Major Product Offerings

Table 28              B-Temia: Major Product Offerings

Table 29              Bionic Power: Major Product Offerings

Table 30              Angel Robotics: Major Product Offerings

Table 31              Axosuits: Major Product Offerings

Table 32              BAMA Teknoloji: Major Product Offerings

Table 33              Biomotum: Major Product Offerings

Table 34              Bionic Yantra: Major Product Offerings

Table 35              Bioservo Technologies: Major Product Offerings

Table 36              Fourier Intelligence: Major Product Offerings

Table 37              FREE Bionics: Major Product Offerings

Table 38              Gloreha Idrogenet: Major Product Offerings

Table 39              Harmonic Bionics: Major Product Offerings

Table 40              HEXAR Humancare: Major Product Offerings

Table 41              Human in Motion Robotics: Major Product Offerings

Table 42              InteSpring: Major Product Offerings

Table 43              Marsi Bionics: Major Product Offerings

Table 44              Global Medical Exoskeleton Market by Modality 2021−2027 ($ million)

Table 45              Global Medical Exoskeleton Market by Modality 2021−2027 (%)

Table 46              North America Medical Exoskeleton Market by Modality 2021−2027 ($ million)

Table 47              North America Medical Exoskeleton Market by Modality 2021−2027 (%)

Table 48              Europe Medical Exoskeleton Market by Modality 2021−2027 ($ million)

Table 49              Europe Medical Exoskeleton Market by Modality 2021−2027 (%)

Table 50              APAC Medical Exoskeleton Market by Modality 2021−2027 ($ million)

Table 51              APAC Medical Exoskeleton Market by Modality 2021−2027 (%)

Table 52              Latin America Medical Exoskeleton Market by Modality 2021−2027 ($ million)

Table 53              Latin America Medical Exoskeleton Market by Modality 2021−2027 (%)

Table 54              Middle East & Africa Medical Exoskeleton Market by Modality 2021−2027 ($ million)

Table 55              Middle East & Africa Medical Exoskeleton Market by Modality 2021−2027 (%)

Table 56              Global Medical Exoskeleton Market by Extremity 2021−2027 ($ million)

Table 57              Global Medical Exoskeleton Market by Extremity 2021−2027 (%)

Table 58              North America Medical Exoskeleton Market by Extremity 2021−2027 ($ million)

Table 59              North America Medical Exoskeleton Market by Extremity 2021−2027 (%)

Table 60              Europe Medical Exoskeleton Market by Extremity 2021−2027 ($ million)

Table 61              Europe Medical Exoskeleton Market by Extremity 2021−2027 (%)

Table 62              APAC Medical Exoskeleton Market by Extremity 2021−2027 ($ million)

Table 63              APAC Medical Exoskeleton Market by Extremity 2021−2027 (%)

Table 64              Latin America Medical Exoskeleton Market by Extremity 2021−2027 ($ million)

Table 65              Latin America Medical Exoskeleton Market by Extremity 2021−2027 (%)

Table 66              Middle East & Africa Medical Exoskeleton Market by Extremity 2021−2027 ($ million)

Table 67              Middle East & Africa Medical Exoskeleton Market by Extremity 2021−2027 (%)

Table 68              Global Medical Exoskeleton Market by Mobility 2021−2027 ($ million)

Table 69              Global Medical Exoskeleton Market by Mobility 2021−2027 (%)

Table 70              North America Medical Exoskeleton Market by Mobility 2021−2027 ($ million)

Table 71              North America Medical Exoskeleton Market by Mobility 2021−2027 (%)

Table 72              Europe Medical Exoskeleton Market by Mobility 2021−2027 ($ million)

Table 73              Europe Medical Exoskeleton Market by Mobility 2021−2027 (%)

Table 74              APAC Medical Exoskeleton Market by Mobility 2021−2027 ($ million)

Table 75              APAC Medical Exoskeleton Market by Mobility 2021−2027 (%)

Table 76              Latin America Medical Exoskeleton Market by Mobility 2021−2027 ($ million)

Table 77              Latin America Medical Exoskeleton Market by Mobility 2021−2027 (%)

Table 78              Middle East & Africa Medical Exoskeleton Market by Mobility 2021−2027 ($ million)

Table 79              Middle East & Africa Medical Exoskeleton Market by Mobility 2021−2027 (%)

Table 80              Global Medical Exoskeleton Market by Type 2021−2027 ($ million)

Table 81              Global Medical Exoskeleton Market by Type 2021−2027 (%)

Table 82              North America Medical Exoskeleton Market by Type 2021−2027 ($ million)

Table 83              North America Medical Exoskeleton Market by Type 2021−2027 (%)

Table 84              Europe Medical Exoskeleton Market by Type 2021−2027 ($ million)

Table 85              Europe Medical Exoskeleton Market by Type 2021−2027 (%)

Table 86              APAC Medical Exoskeleton Market by Type 2021−2027 ($ million)

Table 87              APAC Medical Exoskeleton Market by Type 2021−2027 (%)

Table 88              Latin America Medical Exoskeleton Market by Type 2021−2027 ($ million)

Table 89              Latin America Medical Exoskeleton Market by Type 2021−2027 (%)

Table 90              Middle East & Africa Medical Exoskeleton Market by Type 2021−2027 ($ million)

Table 91              Middle East & Africa Medical Exoskeleton Market by Type 2021−2027 (%)

Table 92              Global Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 93              Global Medical Exoskeleton Market by Geography 2021−2027 (%)

Table 94              Powered Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 95              Powered Medical Exoskeleton Market by Geography 2021−2027 (%)

Table 96              Passive Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 97              Passive Medical Exoskeleton Market by Geography 2021−2027 (%)

Table 98              Upper Extremity Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 99              Upper Extremity Medical Exoskeleton Market by Geography 2021−2027 (%)

Table 100            Lower Extremity Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 101            Lower Extremity Medical Exoskeleton Market by Geography 2021−2027 (%)

Table 102            Stationary Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 103            Stationary Medical Exoskeleton Market by Geography 2021−2027 (%)

Table 104            Mobile Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 105            Mobile Medical Exoskeleton Market by Geography 2021−2027 (%)

Table 106            Rehabilitation Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 107            Rehabilitation Medical Exoskeleton Market by Geography 2021−2027 (%)

Table 108            Augmentation Medical Exoskeleton Market by Geography 2021−2027 ($ million)

Table 109            Augmentation Medical Exoskeleton Market by Geography 2021−2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date